Education
About Us
Working with TipRanks
Follow Us
Lightbridge (LTBR)
NASDAQ:LTBR
Top Page
Lightbridge
(NASDAQ:LTBR)
Select Model
Select Model
Rating:49Neutral
Price Target:
$13.00
▼(-14.30% Downside)
Action:ReiteratedDate:03/03/26
The score is held back primarily by weak financial performance (no revenue, growing losses, and ongoing cash burn). Technicals also remain negative with the stock below major moving averages. These are partially offset by a constructive earnings-call update showing meaningful technical milestones and a much stronger, debt-free cash position that improves near-term runway.
Positive Factors
Strong cash runway and recent financing
A debt-free balance sheet combined with a large cash balance funded by a $176M aftermarket equity raise materially extends runway for multi-year R&D and licensing activities. This reduces near-term financing pressure and allows milestone-driven execution without immediate revenue.
ATR irradiation testing underway
Commencement of ATR irradiation is a durable technical milestone that produces regulator-relevant burnup data critical for licensing and qualification. Successful test campaigns create stickier IP value, shorten commercialization uncertainty, and materially de-risk long-term licensing pathways.
Expanded technical validation and team build-out
Broader INL engagement, validated modeling, peer-reviewed TopFuel publications, and strengthened in-house technical talent increase credibility with regulators, fabricators and utilities. This durable capability enhances likelihood of successful qualification and commercial adoption over time.
Negative Factors
Pre-commercial with no product revenue
Absence of commercial sales means the business is still dependent on R&D funding and milestone payments rather than recurring licensing royalties. Until commercialization occurs, revenue generation remains uncertain and profitability metrics will not validate the business model.
Persistent cash burn and negative free cash flow
Consistent negative operating and free cash flow indicates ongoing reliance on external capital to fund development and operations. Even with current cash, sustained R&D and licensing timelines could necessitate further financing, risking dilution or constrained strategic flexibility.
Regulatory and licensing uncertainty
NRC engagement and formal qualification remain outstanding, creating schedule and execution risk. Regulatory reviews for nuclear fuel are lengthy and outcome-dependent; delays or additional data demands can substantially extend commercial timelines and increase program costs.
Lightbridge (LTBR) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$426.56M
Dividend YieldN/A
Average Volume (3M)839.99K
Price to Earnings (P/E)―
Beta (1Y)2.47
Revenue GrowthN/A
EPS Growth-9.49%
CountryUS
Employees10
SectorIndustrials
Sector Strength72
IndustryElectrical Equipment & Parts
Share Statistics
EPS (TTM)-0.21
Shares Outstanding34,152,060
10 Day Avg. Volume688,055
30 Day Avg. Volume839,993
Financial Highlights & Ratios
PEG Ratio12.82
Price to Book (P/B)1.53
Price to Sales (P/S)0.00
P/FCF Ratio-21.70
Enterprise Value/Market Cap0.31
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-8.50
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Lightbridge Business Overview & Revenue Model
Company DescriptionLightbridge Corporation, together with its subsidiaries, engages in the design and development of nuclear fuel technology under the Lightbridge Fuel name. It focuses on developing and commercializing metallic nuclear fuels that could enhance resistance of nuclear fuel in existing and new nuclear reactors with a meaningful impact on addressing climate change and air pollution. The company was formerly known as Thorium Power, Ltd. and changed its name to Lightbridge Corporation in September 2009. Lightbridge Corporation is headquartered in Reston, Virginia.
How the Company Makes MoneyLightbridge makes money primarily through the development and commercialization of its proprietary nuclear fuel technology. The company's revenue model is centered around licensing its advanced nuclear fuel designs to nuclear utilities and reactor operators. These partnerships allow Lightbridge to generate revenue through licensing fees and royalties based on the usage of their fuel technology in commercial nuclear reactors. Additionally, the company may engage in collaborative research and development agreements with government agencies or other industry stakeholders, which can provide additional funding and partnership opportunities. Lightbridge's growth and financial performance are heavily reliant on the successful adoption of its technology by the nuclear power industry, as well as regulatory approvals and support from governments and international bodies promoting nuclear energy solutions.
Lightbridge Earnings Call Summary
Earnings Call Date:Feb 25, 2026
(Q4-2025)
| % Change Since: |
Next Earnings Date:May 13, 2026
Earnings Call Sentiment Positive
The call conveyed strong technical progress and a materially improved financial position, highlighted by the start of ATR irradiation testing, validated fabrication milestones, expanded INL scope and technical publications, and a cash balance that increased to $201.9 million (approximately +405% year-over-year) funded largely by a $176.0 million equity raise. At the same time, the company remains pre-commercial with significant regulatory, testing, and licensing work still required, used $14.3 million in operations in fiscal 2025, and faces timeline and execution risks tied to future post-irradiation examination and NRC engagement. Overall, positive execution and funding momentum outweigh near-term development and regulatory uncertainties.Q4-2025 Updates
Positive Updates
Irradiation Testing Commenced at Idaho National Laboratory
Began irradiation testing of enriched uranium-zirconium alloy fuel material samples in the Advanced Test Reactor (ATR) at Idaho National Laboratory (November 2025). This is a pivotal technical milestone to generate burnup-dependent data for fuel behavior modeling and regulatory licensing; initial partially irradiated samples expected to be removed in April–May for post-irradiation examination.
Successful Fabrication Milestone and FAST Test Method
Achieved production of enriched uranium-zirconium alloy coupon samples using the proprietary co-extrusion process (June–July 2025). Adopted the Fission Accelerated Steady State Test (FAST) method using higher enrichment (26%–30%) to accelerate test timelines and reach target burnup levels more efficiently for NRC-relevant data.
Expanded Technical Workstream at INL and Validation via Publications
Significantly expanded scope of work at Idaho National Laboratory (review of fuel qualification plan, RELAP5-3D code development, Python code development, and post-irradiation examination). Presented three technical papers at TopFuel 2025 demonstrating safety margins, favorable transient behavior versus conventional UO2, and validated modeling of the co-extrusion fabrication process—strengthening the technical case with regulators, production partners, and utilities.
Talent and Program Build-Out
Substantially beefed up the in-house fuel development team across neutronics, thermal-hydraulics, safety analysis, fuel performance, mechanical engineering, materials, regulatory licensing, and program management to support upcoming phases, regulatory engagement with the U.S. Nuclear Regulatory Commission, and co-extrusion process scale-up.
Strong Cash Position and Successful Equity Financing
Cash and cash equivalents of approximately $201.9 million as of 12/31/2025, up from $40.0 million a year earlier (approximately +405% year-over-year). Raised $176.0 million in net proceeds through an aftermarket equity offering to fund fuel development and program milestones.
Increased Interest Income and Prudent Capital Allocation
Generated approximately $3.6 million in interest income in fiscal 2025, up from $1.3 million in the prior year (approximately +177%), reflecting deployment of cash into U.S. Treasury bills and bank savings. Management emphasized a disciplined, milestone-driven capital allocation strategy focused on licensing and commercialization objectives.
Debt-Free Balance Sheet
Maintained a debt-free capital structure with no convertible securities or other dilutive debt instruments, positioning the company with financial flexibility to pursue strategic opportunities and nondilutive funding sources.
Favorable Macro and Policy Tailwinds
Cited significant U.S. policy support (four executive orders in May 2025) prioritizing nuclear projects and activities aligned with Lightbridge’s offerings (power uprates, plutonium disposition, nuclear for critical infrastructure). Market context: nuclear ~18% of U.S. electricity (2024), ~440 operable reactors globally, ~70 under construction, and >120 in advanced planning—policy pledges to materially expand nuclear capacity by 2050 create potential demand opportunities for fuel that enables higher output and improved economics.
Negative Updates
Pre-Commercial Stage and No Reported Product Revenue
Company remains in development and testing phase with no commercial sales reported on the call; critical work remains on fuel performance testing and regulatory qualification prior to commercialization, exposing the company to execution and timeline risk.
Regulatory and Qualification Work Still Pending
Formal regulatory engagement with the U.S. Nuclear Regulatory Commission is planned to begin this year but has not yet commenced; substantial licensing and qualification activities remain, which introduce schedule risk and regulatory uncertainty for commercialization timelines.
Operating Cash Use and Ongoing Funding Needs
Used approximately $14.3 million in operations during fiscal 2025 to support fuel development and team expansion. While the company strengthened its cash position, continued R&D and licensing efforts will require sustained funding and milestone execution.
Equity Financing Implications
Raised $176.0 million in net proceeds from an aftermarket equity offering to fund activities—provides runway but represents equity issuance that can have dilutive effects for existing shareholders; management noted evaluation of nondilutive funding sources but additional capital needs could arise.
Timeline Uncertainties for Test Results and Post-Irradiation Examination
Initial irradiation began in November 2025 with removal of partially irradiated samples expected April–May; post-irradiation examination is planned later in the year—results and implications for licensing remain to be seen, creating near-term milestone dependence.
Limited Investor Engagement During Call
No questions were submitted during the call, which may indicate limited interactive investor engagement at the time of the update.
Company Guidance
Lightbridge’s guidance focused on an accelerated, milestone-driven development program over the next two to three years: recruit additional personnel across disciplines; continue ATR irradiation testing (irradiation began Nov 2025) using the FAST method with 26%–30% enriched U‑Zr coupons to accelerate burnup; remove the initial partially irradiated samples in the April–May timeframe for post‑irradiation examination this year; refine the phenomena identification and ranking table and fuel qualification plan; begin NRC engagement this year; further develop the co‑extrusion process for rodlets and full‑length rods; select a site and initial deployment plan for an expandable fuel facility; and complete thermal‑hydraulics modeling and experiments to confirm burnout, critical heat flux and other key parameters (INL scope expanded with four new projects and three TopFuel papers presented). Financially, management reported approximately $201.9 million in cash and cash equivalents as of 12/31/2025 (up from ~$40.0 million a year earlier), ~$14.3 million of operating cash used in FY2025, ~$176.0 million in net proceeds raised from aftermarket equity, ~$3.6 million of interest income (vs ~$1.3 million prior year), and a debt‑free balance sheet with no convertible securities, which they said provides an extended runway to execute these plans; market context cited included ~18% of U.S. electricity from nuclear in 2024, ~440 operable reactors (~400 GW), 70 under construction and >120 in advanced planning, and policy goals to materially expand capacity by 2050.Lightbridge Financial Statement Overview
Summary
Income statement and cash flow are very weak (no revenue, widening net losses, and persistent negative free cash flow). The balance sheet is the key offset, with no debt and a sharply larger equity/cash position in 2025 that extends runway, but profitability and self-funding remain absent.Income Statement
The company reports no revenue across the provided annual periods, indicating the business is still pre-commercial or operating without meaningful sales. Losses are persistent and sizable, with net income declining from about -$7.5M (2022) / -$7.9M (2023) to -$11.8M (2024) and -$19.6M (2025), suggesting rising operating spend. With negative operating profit in recent years and no demonstrated revenue ramp, profitability and earnings quality remain weak.12
Very Negative
Balance Sheet
A key strength is the absence of debt in all reported years, which limits financial leverage risk. Equity expanded sharply in 2025 to ~$203.0M (from ~$40.5M in 2024), and total assets rose to ~$203.8M, improving balance-sheet capacity to fund operations. The main weakness is ongoing negative returns on equity (loss-making), meaning shareholder capital is not currently generating profits despite the larger equity base.58
Neutral
Cash Flow
Cash burn remains the core issue: operating cash flow and free cash flow are negative every year provided. Outflows increased to about -$14.3M in 2025 versus -$9.5M in 2024, indicating higher cash usage alongside widening losses. While free cash flow improved versus earlier years (e.g., roughly -$11.1M in 2021), the company is still not self-funding and will likely rely on its balance-sheet resources or external financing until revenue materializes.22
Negative
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA | -19.58M | -11.79M | -9.04M | -7.79M | -8.00M |
| Net Income | -19.58M | -11.79M | -7.91M | -7.50M | -7.84M |
Balance Sheet | |||||
| Total Assets | 203.83M | 40.95M | 29.40M | 29.47M | 24.96M |
| Cash, Cash Equivalents and Short-Term Investments | 201.86M | 39.99M | 28.60M | 28.90M | 24.75M |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 847.45K | 424.58K | 486.33K | 350.33K | 171.52K |
| Stockholders Equity | 202.99M | 40.53M | 28.91M | 29.12M | 24.79M |
Cash Flow | |||||
| Free Cash Flow | -14.28M | -9.49M | -6.49M | -6.77M | -11.05M |
| Operating Cash Flow | -14.28M | -9.49M | -6.48M | -6.76M | -11.04M |
| Investing Cash Flow | -10.53K | 0.00 | -640.00 | -6.64K | -16.02K |
| Financing Cash Flow | 176.16M | 20.89M | 6.18M | 10.92M | 14.27M |
Lightbridge Technical Analysis
Negative
15.17
Price Trends
14.90
Negative
17.44
Negative
16.18
Negative
Market Momentum
-0.72
Negative
39.95
Neutral
44.75
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For LTBR, the sentiment is Negative. The current price of 15.17 is above the 20-day moving average (MA) of 13.59, above the 50-day MA of 14.90, and below the 200-day MA of 16.18, indicating a bearish trend. The MACD of -0.72 indicates Negative momentum. The RSI at 39.95 is Neutral, neither overbought nor oversold. The STOCH value of 44.75 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for LTBR.
Lightbridge Risk Analysis
Lightbridge disclosed 2 risk factors in its most recent earnings report. Lightbridge reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 1 New Risks
Lightbridge Peers Comparison
UnderperformOutperform
Sector (63)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | $1.36B | -100.04 | 151.33% | 6.02% | 2.28% | 534.60% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
56 Neutral | $1.92B | -0.66 | -55.98% | ― | ― | -394.37% | |
52 Neutral | $1.11B | -10.09 | -60.52% | ― | 45.98% | 44.14% | |
51 Neutral | $378.55M | -2.71 | -26.12% | ― | 41.05% | -1.02% | |
49 Neutral | $426.56M | -10.78 | -16.08% | ― | ― | -9.49% | |
45 Neutral | $738.94M | -7.26 | -22.60% | ― | 25.24% | -12.96% |
* Industrials Sector Average
LTBR
Lightbridge
12.83
2.62
25.66%
ENR
Energizer Holdings
19.03
-9.21
-32.60%
FCEL
Fuelcell Energy
8.57
2.46
40.26%
TE
T1 Energy
7.10
5.62
379.73%
ENVX
Enovix
5.11
-3.51
-40.72%
SLDP
Solid Power
3.33
2.20
194.69%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.